The collaboration between hyperCORE's alliance partner companies is reflective of an industry demand for more streamlined and efficient models for the delivery of clinical trials. Each alliance partner is thoroughly vetted prior to acceptance, reflecting hyperCORE's values in superior quality, experience, efficiency and industry leadership. To find out more about becoming an alliance partner in our super network of clinical research sties, contact us today at [email protected]!
Benchmark Research is a leader in the clinical research industry with experience in Phase I-IV trials. Benchmark has five geographically diverse, multi-therapeutic research centers. Our database of over 90,000 patients gives us access to a large number of subjects, ensuring high volume patient recruitment and retention. We have enrolled over 40,000 subjects in more than 1,025 trials since our inception in 1997. Our trial experience covers a wide range of indication areas, including diagnostics, cardiovascular, infectious disease, musculoskeletal, endocrinology, women’s health, allergy and vaccines. We have conducted trials with 100+ Sponsors, providing them with unsurpassed trial execution, clean data, and a steadfast pledge to patient safety.
In 2021, IACT Health, LMC Manna Research, and True North Memory Clinic joined forces making Centricity Research the largest consolidated research network in North America. Collectively, the new company has more than 40 sites, access to over 1.6 million patients, and more than 150 active investigators across Canada and the southeastern United States. Centricity Research is a fully centralized Integrated Research Organization (IRO) specializing in over 30 therapeutics.
FOMAT Medical Research was a spin off of Diverse Research Solutions (DRS) to expand the diversity focus. FOMAT acquired DRS six years later and established their headquarters in California. They have more than 10 years experience participating in Phase 1 through Phase 4 Clinical Trials in most therapeutic areas. FOMAT relies on a highly experienced clinical research team with professional expertise to assist sponsors and CROs in reaching their project goals quickly and effectively. All sites are pre-qualified to ensure their performance will exceed expectations, both in terms of speed and quality. Once in the network, our sites abide by established quality standards.
Founded in 2007, AGA Clinical Trials is a clinical research company offering services in the pharmaceutical, medical devices, and biotechnology industry. The organization conducts Phase I to IV clinical diversity trials in adult and pediatric populations in close to thirteen medical specialties. Our ACRP/SOCRA certified personnel and Investigators allow for consistent quality, improved efficiency, and reduced costs across all aspects of research. Among top enrollers for 92% of trials involved provided the recognition of IQVIA, PAREXEL, and COVANCE as a partner site. AGA Clinical Trials has contributed to helping 30 medications achieve FDA approvals since 2007.
Our US site in the Miami area, and our Ecuador, South America site is ready and pre-qualified for conducting the most rigorous trials required by the industry. Our South American site is one of the only certified institutions by NIH for vaccine trials in our country.
We are a multi-specialty clinical research site in Omaha Nebraska comprised of internal medicine, colon and rectal surgeons, and infectious disease, dermatology, psychiatric, and pediatric physicians. Our physicians have over 15 years of research expertise and are board-certified in family practice, internal medicine, colon and rectal surgery, infectious disease, dermatology, psychiatry, and pediatrics. Quality Clinical Research, Inc. has conducted over 700 studies in these therapeutic areas.
Founded in 2006, TrueBlue Clinical Research, formerly MOORE Clinical Research, Inc. is a 3-site research center located in the Tampa Bay metro area, with a proud reputation and consistent record of quality, integrity and reliability. We specialize in conducting Phase II-IV clinical trials in multi-therapeutic areas. Our team comes with over 150 years of research experience collectively and are highly trained and credentialed Board-Certified Physicians, Registered Nurses, LPNs, Research Coordinators & Research Assistants with experience in Dermatology, Immunology, Internal Medicine, Neurology and Mental Health research. The experienced team at TrueBlue Clinical Research is a team you can always rely on to maintain the high standards expected by the industry, to consistently follow established standards and regulations and to always deliver prompt, accurate results.
Lucas Research, located in Morehead City, NC is a world-class clinical research site focusing mainly on research for diseases of the endocrine system. We feel this is a great way to serve our patients as well as benefit millions more by working to develop more effective medications for those struggling with diabetes, weight loss, and other endocrine diseases.
Lucas Research is also a specialty medical facility and focus on the diagnosis and treatment of diseases of the endocrine system. Endocrinology is the subspecialty of Internal Medicine focusing on hormonal and glandular problems such as the pancreas, reproductive system, thyroid disease, diabetes, and its complications, pituitary diseases, osteoporosis, calcium metabolism, and adrenal gland diseases, growth disorders, and disorders of sexual development.
Alcanza Clinical Research is the next-generation site network organized to support the most significant demands in our industry: diverse patient access, efficient enrollment performance, and clinical quality. Alcanza practice inclusive research that delivers education and clinical trial options to all people on their terms.
Formerly known as the Nutrasource Clinical Trial Site, Apex Trials has been conducting clinical trials for the past 20 years with 1300+ clinical trials conducted across our team. Headquartered in Southwestern Ontario, Canada, Apex Trials is a premium clinical trial site, conducting studies in both the pharmaceutical and nutraceutical industries.
The primary focus of Apex Trials is Phase I / Pharmacokinetic studies – Phase IV Studies targeting cardiovascular disease, hypertension, dyslipidemia, diabetes, irritable bowel syndrome, and weight management.
Input your search keywords and press Enter.